fluorodopa f 18 has been researched along with Carcinoma, Neuroendocrine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Chabrier, G; Imperiale, A; Rotania, M | 1 |
| Capotosti, A; Indovina, L; Lanni, V; Lorusso, M; Rufini, V; Taralli, S | 1 |
| Despot, M; Golubić, AT; Huić, D; Kusačić Kuna, S; Mutvar, A; Pasini Nemir, E; Samardžić, T; Žuvić, M | 1 |
| Göllner, A; Hacker, M; Hartenbach, M; Hartenbach, S; Karanikas, G; Mayerhoefer, M; Mazal, P; Rasul, S; Rebhan, K | 1 |
| Bodner, G; Brammen, L; Karanikas, G; Koperek, O; Niederle, B; Niederle, MB; Riss, P; Scheuba, C; Selberherr, A | 1 |
| Balogova, S; Kaliska, L; Kunikowska, J; Montravers, F; Slavikova, K; Talbot, JN; Treglia, G; Vereb, M | 1 |
| Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M | 1 |
| Santhanam, P; Taïeb, D | 1 |
| Abdullah, AE; Archier, A; Guerin, C; Heimburger, C; Henry, JF; Imperiale, A; Morange, I; Mundler, O; Palazzo, FF; Schneegans, O; Sebag, F; Taïeb, D | 1 |
| Ahonen, A; Arola, J; Ebeling, T; Heiskanen, I; Kajander, S; Kauhanen, S; Korsoff, P; Lisinen, I; Minn, H; Nuutila, P; Sane, T; Schalin-Jäntti, C; Schildt, J; Seppänen, M; Väisänen, M; Välimäki, MJ; Virtanen, S | 1 |
| Ambrosini, V; Castaldi, P; Cremonini, N; de Waure, C; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Santimaria, M; Treglia, G; Versari, A; Villani, MF | 1 |
| Boulanger, C; Imperiale, A; Ollier, JC; Roedlich, MN; Rust, E; Schneegans, O | 1 |
| Cocciolillo, F; de Waure, C; Di Nardo, F; Giordano, A; Poscia, A; Rufini, V; Treglia, G | 1 |
| Ambrosini, V; Castaldi, P; Cremonini, N; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Treglia, G; Versari, A; Villani, MF | 1 |
| Brouwers, AH; de Groot, JW; Hofstra, RM; Koopmans, KP; Links, TP; Muller Kobold, AC; Plukker, JT; van der Horst-Schrivers, AN; Verbeek, HH | 1 |
| Fanti, S; Nanni, C; Rubello, D | 1 |
5 review(s) available for fluorodopa f 18 and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?
Topics: Amines; Blood Glucose; Bone and Bones; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms | 2012 |
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
1 trial(s) available for fluorodopa f 18 and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Kinetics; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
10 other study(ies) available for fluorodopa f 18 and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2019 |
Which Is the Optimal Scan Time of 18F-DOPA PET/CT in Patients With Recurrent Medullary Thyroid Carcinoma?: Results From a Dynamic Acquisition Study.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Thyroid Neoplasms; Time Factors; Whole Body Imaging | 2020 |
The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms; Young Adult | 2017 |
[
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2018 |
Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Neuroendocrine; Child; Clinical Decision-Making; Dihydroxyphenylalanine; False Negative Reactions; False Positive Reactions; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tumor Burden; Ultrasonography; Young Adult | 2018 |
(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2016 |
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Recurrence; Retrospective Studies; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Ileal Neoplasms; Incidental Findings; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Young Adult | 2012 |
18F-DOPA PET and PET/CT.
Topics: Brain; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Image Enhancement; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |